Elitra Pharmaceuticals' Series C Round

Elitra Pharmaceuticals raised a round of funding on August 21, 2000.

Antimicrobial functional genomics company focused on the identification, development and commercialization of antimicrobial compounds that target essential gene products of pathogenic organisms. Elitr…

Articles about Elitra Pharmaceuticals' Series C Round: